News
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
9h
GlobalData on MSNDanone launches Oikos yogurt drink aimed at GLP-1 users
Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...
21h
Everyday Health on MSNGLP-1 Pill Helped People With Obesity Lose Almost 30 Pounds in New Trial
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.
The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results